These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10963129)

  • 1. Apoptosis regulating genes in neuroendocrine tumors.
    Liu WH; Wang DG
    Histol Histopathol; 2000 Jul; 15(3):851-9. PubMed ID: 10963129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in neuroendocrine tumours.
    Wang DG
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):1-9. PubMed ID: 10468958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis.
    Wang DG; Liu WH; Johnston CF; Sloan JM; Buchanan KD
    Am J Pathol; 1998 Jun; 152(6):1407-13. PubMed ID: 9626044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the apoptosis-suppressing gene BCL-2 in pheochromocytoma is associated with the expression of C-MYC.
    Wang DG; Johnston CF; Marley JJ; Phenix KV; Atkinson AB; Russell CF; Buchanan KD
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1949-52. PubMed ID: 9177412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors.
    Manjarrez ME; Ocadiz R; Valle L; Pacheco C; Marroquin A; De la Torre C; Selman M; Gariglio P
    Clin Cancer Res; 2006 Dec; 12(23):6946-51. PubMed ID: 17145812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.
    Zalata KR; Elshal MF; Foda AA; Shoma A
    Tumour Biol; 2015 Aug; 36(8):6579-84. PubMed ID: 25840688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of apoptosis and cell-proliferation regulating genes in mycosis fungoides.
    Kandolf Sekulović L; Cikota B; Jović M; Skiljević D; Stojadinović O; Medenica L; Magić Z
    J Dermatol Sci; 2009 Jul; 55(1):53-6. PubMed ID: 19324523
    [No Abstract]   [Full Text] [Related]  

  • 11. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on apoptosis of leukemia cell line NB4 transfected with WT1 gene].
    Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):989-95. PubMed ID: 16403265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of c-Myc activity and apoptosis in vivo.
    Alarcon RM; Rupnow BA; Graeber TG; Knox SJ; Giaccia AJ
    Cancer Res; 1996 Oct; 56(19):4315-9. PubMed ID: 8813114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
    Taylor AC; Schuster K; McKenzie PP; Harris LC
    Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
    Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
    Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy.
    Kroger LA; DeNardo GL; Gumerlock PH; Xiong CY; Winthrop MD; Shi XB; Mack PC; Leshchinsky T; DeNardo SJ
    Cancer Biother Radiopharm; 2001 Jun; 16(3):213-25. PubMed ID: 11471486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients.
    Wu X; Cai ZD; Lou LM; Zhu YB
    Cancer Epidemiol; 2012 Apr; 36(2):212-6. PubMed ID: 21890444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 can provoke apoptosis in p53-deficient Hep3B cells with delayed kinetics relative to wild-type p53.
    Stähler F; Roemer K
    Oncogene; 1998 Dec; 17(26):3507-12. PubMed ID: 10030675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.